Senna-s Tablet
NDC Package 72090-030-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Senna-s tablets is take preferably at bedtime or as directed by a doctor. This formulation utilizes a tablet delivery system. Marketed by Pioneer Life Sciences, Llc, this product is identified by NDC 72090-030 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
72090-030-20
Package Description
200 TABLET in 1 BOTTLE
Product Code
72090-030
11-Digit Billing Format
72090003020
RxNorm Crosswalk
  • RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
  • RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
  • RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet

Clinical Specifications

Proprietary Name
Senna-s
Non-Proprietary Name
Senna-s
Substance Name
Docusate Sodium; Sennosides
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Take preferably at bedtime or as directed by a doctor.

Regulatory & Marketing

Labeler Name
Pioneer Life Sciences, Llc
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-29-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72090-030-20 identifies a specific commercial package of 200 tablet in 1 bottle of Senna-s, a human over the counter drug labeled by Pioneer Life Sciences, Llc. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pioneer Life Sciences, Llc on June 29, 2020. The current certification is valid through December 31, 2026.

How is this Pioneer Life Sciences, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72090003020. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72090-030-20
11-Digit CMS (5-4-2)
72090-0030-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.